The United States Patent Trial and Appeal Board has handed a win to Chinese-American synthetic biologist Feng Zhang (張鋒) and his team from the Massachusetts Institute of Technology (MIT) in a dispute over patents of the gene editing technology known as CRISPR.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan's ambassador to Holy See presents Letter of Credence
07/04/2025 10:55 AM - Society
Brief showers forecast for Friday; tropical storms may be forming
07/04/2025 10:34 AM - Business
U.S. dollar down in Taipei trading
07/04/2025 10:20 AM - Society
Taiwan headline news
07/04/2025 09:57 AM - Business
Taiwan shares open higher
07/04/2025 09:07 AM